文献速递免疫规划传染病防控与疫情报告卫生政策与健康促进

基于健康信念模型的香港COVID-19疫苗接受度:一项基于人群的调查

Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong.
PubMed 文献 · Vaccine · 2021-01-06

研究在香港第三波COVID-19疫情高峰期(2020年7月27日至8月27日)对≥18岁成人进行随机电话调查,成功访谈1200人(应答率55%),经人口分布调整后总体疫苗接受率为37.2%(95%CI 34.5-39.9%)。多因素回归显示政府推荐(aOR=10.2,95%CI 6.54-15.9,p<0.001)是接受度的最强驱动因素,而感知易感性无显著关联。

要点

  • 政府推荐是疫苗接受度的最强驱动因素(aOR=10.2)。
  • 感知严重性、获益、行动提示、自报健康结果及对医疗系统或制造商的信任为正相关因素。
  • 感知障碍和感知危害为负相关因素,感知易感性无显著关联。

核心结论

  • 政府推荐是COVID-19疫苗接受度的重要驱动因素,而感知易感性与之无显著关联。
  • 健康信念模型构念和独立预测因素可为疫苗接种策略的制定与实施提供证据。

研究设计与样本

  • 基于人群的随机电话调查,于2020年7月27日至8月27日香港第三波COVID-19疫情高峰期进行。
  • 所有≥18岁成人符合条件,共完成1200成功电话访谈(应答率55%)。
  • 调查内容包括社会人口学特征、自报健康状况、信任量表和自报健康结果,采用多因素回归分析检验独立关联。

主要发现

  • 经人口分布调整后总体疫苗接受率为37.2%(95%CI 34.5-39.9%)。
  • 预测接受率随年龄呈「J型」模式,年轻成人(18-24岁)较高,随后随年龄线性增加。
  • 感知严重性、疫苗感知获益、行动提示、自报健康结果及对医疗系统或疫苗制造商的信任为接受度的正相关因素。
  • 感知获取障碍和感知危害为接受度的负相关因素;感知感染易感性无显著关联。
  • 政府推荐为接受度的最强驱动因素(aOR=10.2,95%CI 6.54-15.9,p<0.001)。

临床怎么用

  • 疫苗接种策略可重视政府推荐的作用,以提升公众接受度。
  • 针对感知障碍、感知危害及对疫苗平台和制造商的信任不足进行沟通干预。
  • 不应仅依赖提升感知易感性来促进接种,需综合健康信念模型构念和独立预测因素制定策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Vaccines for COVID-19 are anticipated to be available by 2021. Vaccine uptake rate is a crucial determinant for herd immunity. We examined factors associated with acceptance of vaccine based on (1). constructs of the Health Belief Model (HBM), (2). trust in the healthcare system, new vaccine platforms and manufacturers, and (3). self-reported health outcomes. METHODS: A population-based, random telephone survey was performed during the peak of the third wave of COVID-19 outbreak (27/07/2020 to 27/08/2020) in Hong Kong. All adults aged ≥ 18 years were eligible. The survey included sociodemographic details; self-report health conditions; trust scales; and self-reported health outcomes. Multivariable regression analyses were applied to examine independent associations. The primary outcome is the acceptance of the COVID-19 vaccine. RESULTS: We conducted 1200 successful telephone interviews (response rate 55%). The overall vaccine acceptance rate after adjustment for population distribution was 37.2% (95% C.I. 34.5-39.9%). The projected acceptance rates exhibited a "J-shaped" pattern with age, with higher rates among young adults (18-24 years), then increased linearly with age. Multivariable regression analyses revealed that perceived severity, perceived benefits of the vaccine, cues to action, self-reported health outcomes, and trust in healthcare system or vaccine manufacturers were positive correlates of acceptance; whilst perceived access barriers and harm were negative correlates. Remarkably, perceived susceptibility to infection carried no significant association, whereas recommendation from Government (aOR = 10.2, 95% C.I. 6.54 to 15.9, p < 0.001) was as the strongest driving factor for acceptance. Other key obstacles of acceptance included lack of confidence on newer vaccine platforms (43.4%) and manufacturers without track record (52.2%), which are of particular relevance to the current context. CONCLUSIONS: Governmental recommendation is an important driver, whereas perceived susceptibility is not associated with acceptance of COVID-19 vaccine. These HBM constructs and independent predictors inform evidence-based formulation and implementation of vaccination strategies.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Wong MCS, Wong ELY, Huang J, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021. PMID: 33461834. doi:10.1016/j.vaccine.2020.12.083

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。